Provenienza dei contatti di primo grado di Rohan Lathia
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Holding Company | Biotechnology | 31 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Rohan Lathia tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Investor Relations Contact | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Chief Executive Officer Founder Director/Board Member | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO Director/Board Member | |
Patient Square Capital
 Patient Square Capital Investment ManagersFinance Patient Square Capital is an Independent Private Equity/Venture Capital firm founded by Jim Momtazee and Maria Walker. Patient Square Capital is headquartered in Menlo Park. | Investment Managers | Private Equity Investor Private Equity Investor | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Founder Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
| CVS HEALTH CORPORATION | Drugstore Chains | Investor Relations Contact | |
| FSD PHARMA INC. | Biotechnology | Chief Executive Officer | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
| The University of Utah Health Sciences Center | Corporate Officer/Principal | ||
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of California, Davis | College/University | Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The North Carolina Department of Commerce | General Government | Corporate Secretary | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Sales & Marketing | |
| JPMORGAN CHASE & CO. | Major Banks | Corporate Officer/Principal | |
| FORTREA HOLDINGS INC. | Miscellaneous Commercial Services | Director/Board Member | |
Arteriocyte, Inc.
 Arteriocyte, Inc. Pharmaceuticals: MajorHealth Technology Arteriocyte, Inc. provides clinical stage research and develops biotechnology. It develops novel stem cell products and medical devices for unmet clinical needs. The company was founded by Vincent J. Pompili and Mary J. Laughlin in 2004 and is headquartered in Cleveland, Ohio. | Pharmaceuticals: Major | Sales & Marketing | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Arteriocyte Medical Systems, Inc.
 Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Medical Specialties | Sales & Marketing | |
| ABIOMED, INC. | Medical Specialties | Investor Relations Contact | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Investment Banks/Brokers | Sales & Marketing | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Investor Relations Contact | |
| North Carolina Department of Administration | General Government | Corporate Secretary | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Banyan Biomarkers, Inc.
 Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
HistoSonics, Inc.
 HistoSonics, Inc. Medical SpecialtiesHealth Technology HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
| St. Joseph's University | College/University | Undergraduate Degree | |
Manhattan Institute For Policy Research, Inc.
 Manhattan Institute For Policy Research, Inc. Miscellaneous Commercial ServicesCommercial Services Manhattan Institute For Policy Research, Inc. develops and disseminate new ideas for greater economic choice and individual responsibility. It focuses on economic growth, education, energy and environment, health care, legal reform, public sector, race and urban policy. The company was founded by Antony Fisher and William J. Casey in 1977 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| ONCOCYTE CORPORATION | Biotechnology | Director/Board Member | |
| National Comprehensive Cancer Network Foundation | Director/Board Member | ||
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Irlanda | 5 |
| Regno Unito | 3 |
| Canada | 2 |
| Svezia | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 8 |
| Finance | 6 |
| Health Services | 3 |
| Government | 3 |
Posizioni
| Director/Board Member | 141 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 51 |
| Undergraduate Degree | 22 |
| Chairman | 18 |
Contatti più connessi
| Insiders | |
|---|---|
| Andrew von Eschenbach | 32 |
| Jean-Pierre Garnier | 28 |
| Owen Hughes | 23 |
| Sean Murphy | 22 |
| George Martin | 20 |
| Catherine Friedman | 20 |
| Jennifer Jarrett | 18 |
| Willard Dere | 16 |
| Alex Albert | 11 |
| A. Sanders | 11 |
| Laura Furmanski | 10 |
| James Chopas | 10 |
| Travis Wilson | 9 |
| Mark Conley | 9 |
| Susan Vissers Lisa | 9 |
- Borsa valori
- Insiders
- Rohan Lathia
- Connessioni Società